NCT05036109 2026-02-10
DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease
M.D. Anderson Cancer Center
Phase NA Completed
Clinical Trials
38 trialsNCT04184921 2026-02-03
Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 2 Completed
NCT04379999 2025-08-07
Atorvastatin ± Aspirin in Lynch Syndrome Syndrome
Fox Chase Cancer Center
Phase EARLY_PHASE1 Completed
NCT00357682 2025-05-01
AspECT
University of Oxford
Phase 3 Completed
NCT03245489 2025-01-31
Anti-platelet + Pembro for H&N Tumors
Medical University of South Carolina
Phase 1 Completed
NCT04534218 2024-12-20
REPROGRAM-01
Centre Hospitalier Universitaire de Besancon
Phase 2 Completed
NCT00482261 2024-11-08
A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression
Peter MacCallum Cancer Centre, Australia
Phase 2 Completed
NCT03378297 2024-10-30
IMPACT
Haukeland University Hospital
Phase EARLY_PHASE1 Completed
NCT03003325 2024-09-19
Low-PV
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Phase 2 Completed
NCT05507645 2024-09-05
PUMICE
Beijing Tiantan Hospital
Phase 3 Completed
NCT05865548 2024-08-13
Addition of Aspirin to Standard of Care in Oral Cancer
Banaras Hindu University
Phase 2/3 Completed
NCT04243122 2024-05-29
AIRPORT-MPN
Ottawa Hospital Research Institute
Phase 2 Completed
NCT03728179 2024-02-20
RACIN
Centre Hospitalier Universitaire Vaudois
Phase 1 Completed
NCT02834403 2023-12-15
L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients
The Methodist Hospital Research Institute
Phase 1/2 Completed
NCT00578721 2023-07-07
Trial of Aspirin and Arginine Restriction in Colorectal Cancer
University of California, Irvine
Phase 2 Completed
NCT03103152 2023-03-29
PROVENT
Queen Mary University of London
Phase 2/3 Completed
NCT00055731 2023-01-18
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
UNICANCER
Phase 3 Completed
NCT03396952 2022-10-13
Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma
University of California, San Francisco
Phase 2 Completed
NCT04352439 2022-09-26
Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy
Duke University
Phase 4 Completed
NCT04062032 2022-02-18
Metabolomic and Inflammatory Effects of Oral Aspirin (ASA) in Subjects at Risk for Melanoma
University of Utah
Phase 2 Completed
NCT04066725 2022-02-18
Aspirin as an Ultraviolet (UV) Protectant in Human Subjects at Risk for Melanoma
University of Utah
Phase 2 Completed
NCT01646437 2021-09-16
TIPS-3
Population Health Research Institute
Phase 3 Completed
NCT03192059 2021-09-08
PRIMMO
University Hospital, Ghent
Phase 2 Completed
NCT03093207 2020-11-17
Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis
Universidade Estadual Paulista Júlio de Mesquita Filho
Phase 2/3 Completed
NCT01763606 2020-08-14
Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00272324 2020-03-13
Aspirin/Folate Prevention of Large Bowel Polyps
Dartmouth-Hitchcock Medical Center
Phase 2/3 Completed
NCT01727427 2019-08-08
Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients
G. d'Annunzio University
Completed
NCT02285738 2019-05-08
Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT01696760 2018-12-05
Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT01355705 2018-09-18
Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma
Stanford University
Phase 1/2 Completed
NCT01042704 2017-07-31
Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma
University of Pittsburgh
Phase 1 Completed
NCT01259817 2017-01-11
Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)
Icahn School of Medicine at Mount Sinai
Phase 2 Completed
NCT02062255 2016-10-26
Impact of COX2 on Sera Biomarkers From Obese Subjects
The University of Texas Health Science Center at San Antonio
Phase EARLY_PHASE1 Completed
NCT00002527 2016-07-04
Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00234299 2016-05-25
Effects of ASA on Prostate Tissue
University of Washington
Phase NA Completed
NCT00691704 2014-08-19
Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy
Duke University
Phase 2 Completed
NCT00258245 2013-04-29
Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
Barbara Ann Karmanos Cancer Institute
Phase 1 Completed
NCT00000479 2012-06-15
WHS
Brigham and Women's Hospital
Phase 3 Completed